In our study, DDR1‐positive human colon cancer xenografts resistant to oxaliplatin were eliminated by T4H11‐DM4 in vivo, which indicated that the combination therapy of T4H11‐DM4 and other small molecular inhibitor might be good option to overcome chemotherapy‐resistance. Here, DDR1 is linked to colonic neoplasm.